Irmgard Boesl

Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study

Guy Hans, R. Sabatowski, Andreas Binder et al. · Current Medical Research and Opinion · 2009 · 91 citations

Thrombolysis with recombinant unglycosylated single-chain urokinase-type plasminogen activator (saruplase) in acute myocardial infarction: influence of heparin on early patency rate (LIMITS study)

Ulrich Tebbe, Jürgen Windeler, Irmgard Boesl et al. · Journal of the American College of Cardiology · 1995 · 38 citations

Thrombosis, Early Patency Rate, Limits Study +9

Lidocaine medicated plaster, an additional potential treatment option for localized post-surgical neuropathic pain: efficacy and safety results of a randomized, placebo-controlled trial

Mariana Palladini, Irmgard Boesl, Simone Koenig et al. · Current Medical Research and Opinion · 2019 · 26 citations

Evaluation of the Population Pharmacokinetic Properties of Lidocaine and its Metabolites After Long-Term Multiple Applications of a Lidocaine Plaster in Post-Herpetic Neuralgia Patients

Roberta Bursi, Chiara Piana, Joachim Grevel et al. · European Journal of Drug Metabolism and Pharmacokinetics · 2017 · 13 citations · Full text